.png)
Inmagene LLC
- Address
- 12526 High Bluff Drive Ste 345
Sponsor Overview
Specializations
Atopic Dermatitis
Inmagene LLC focuses its clinical research on atopic dermatitis, with an emphasis on adult patients living with moderate-to-severe disease. Its studies examine treatment effects on eczema burden and clinical signs of skin inflammation.
- Atopic dermatitis
- Moderate-to-severe eczema
- Inflammatory skin disease
The sponsor’s research activity in this area reflects a concentrated interest in dermatologic conditions where control of disease activity and symptom reduction are central therapeutic goals.
Dermatology Safety and Tolerability
The clinical program also places strong attention on safety and tolerability in adults with atopic dermatitis, including the monitoring of treatment-emergent adverse events in a dermatology setting.
- Adverse events
- Safety assessment
- Tolerability evaluation
This area of interest highlights the sponsor’s involvement in therapeutic development for chronic skin disease where both efficacy and patient safety are key clinical priorities.
Immunology-Driven Skin Disease
Inmagene LLC’s research landscape extends into immune-mediated skin disease, with a therapeutic focus on conditions shaped by persistent inflammatory activity and immune dysregulation.
- Immune-mediated inflammation
- Chronic inflammatory dermatoses
- Skin immune modulation
Its funded trials reflect interest in therapies aimed at modifying the underlying inflammatory features of atopic dermatitis.
Adult Therapeutic Development
The sponsor’s clinical activity is centered on adult participants, supporting research in a population with ongoing treatment needs and long-term disease management challenges.
- Adult dermatology
- Chronic disease management
- Symptom control
This focus aligns with therapeutic development for persistent skin inflammation in adults requiring effective management of disease activity and associated symptoms.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| A Phase 2b, Multicenter, Randomized, Double-blinded, Placebo-controlled, Parallel-group, Dose-finding Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants with Moderate-to-Severe Atopic Dermatitis |  Czechia Germany Hungary Poland Spain | Not Yet Recruiting |
| Evaluation of Safety, Pharmacokinetics, and Efficacy of IMG-007 in Adults with Moderate-to-Severe Atopic Dermatitis | Germany Poland | Not Recruiting |
Data & Insights
This sponsor works with 1 molecule, of which 1 is not being studied by other sponsors.
This sponsor has worked with 29 sites across their trial portfolio.
Therapeutic Focus
- 1.Immune System Diseases2 trials322 other sponsors
Partnered Research Centres
29 centres- Address
- Nyiri Ut 38, 6000 Kecskemét
- Address
- Carrer De La Feixa Llarga S/N, 08907 L'hospitalet De Llobregat
- Address
- 28. Rijna 3348/65, Moravska Ostrava, 702 00 Moravska Ostrava A Privoz
- Address
- Ul. Henryka Sienkiewicza 23, 30-033 Krakow
- Address
- Hindenburgdamm 30, Lichterfelde, 12203 Berlin
- Address
- Kaszasdulo Utca 5, 1033 Budapest
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Inmagene LLC.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.